Ursane hybrids with 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines and study of their inhibition of main SARS-CoV-2 protease

•New ursane hybrids with tetrazole and 5-aminothiatriazoles were synthesized.•New compounds were tested in vitro for SARS-CoV-2 3CLpro inhibition.•Hybrids with 1-tetrazol-5-thione inhibited 3CLpro and were non-toxic for Vero cells.•Molecular docking assumed a disulfide bonding between tetrazole-thio...

Full description

Saved in:
Bibliographic Details
Published inSteroids Vol. 220; p. 109638
Main Authors Popov, Sergey A., Shults, Elvira E., Baev, Dmitry S., Chirkova, Varvara Yu, Volosnikova, Ekaterina A., Belenkaya, Svetlana V., Shcherbakov, Dmitry N., Pokrovsky, Mikhail.A., Hamad, Mohammad S., Pokrovsky, Andrey G.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.08.2025
Subjects
Online AccessGet full text

Cover

Loading…
Abstract •New ursane hybrids with tetrazole and 5-aminothiatriazoles were synthesized.•New compounds were tested in vitro for SARS-CoV-2 3CLpro inhibition.•Hybrids with 1-tetrazol-5-thione inhibited 3CLpro and were non-toxic for Vero cells.•Molecular docking assumed a disulfide bonding between tetrazole-thiol and cysteine of 3CLpro.•The external bonding of triterpenoid is essential for the affinity with the enzyme. A series of new heterocyclic ursane and 28-norursane hybrids − derivatives of 5-amino-1,2,3,4-thiatriazole, 1-tetrazole–5-thione, and 1-tetrazole–5-amines were prepared. Reacting triterpenoids holding NCS groups at different distances from the pentacyclic backbone with hydrazine hydrate resulted in ursane-derived hydrazinecarbothioamides. Subsequent nitrosation afforded terpenoid derivatives of 5-amino-1,2,3,4-thiatriazole. Heterocyclization of amino-thioureas with 3β-acetoxyurs-12-en-28-yl substituent under the action of Hg(OAc)2-NaN3 led to hybrids of 1-tetrazole–5-amines. 1-Tetrazole–5-thiones with different positions of heterocycle relative to the triterpene skeleton were prepared by coupling sodium azide with triterpene isothiocyanates. The activity of the new heterocyclic derivatives as inhibitors of 3CLpro of SARS-CoV-2 was investigated. Remarkable inhibition was observed for the 1-tetrazole-5-thione hybrids of triterpenoids. The highest activity among the studied compounds was provided by the combination of a 1-tetrazole-5-thione moiety at the C(28)H2 group of the ursane frame having a free OH group at the 3-position. Molecular docking assumed the covalent binding of 3CLpro via the formation of a disulfide bond between the thiol groups of the catalytic Cys145 and the tetrazole heterocycle of the new hybrid compounds. The triterpenoid backbone provided multiple external hydrophobic contacts essential for the stability of the complex. The results demonstrate the potential of heterocyclic thione hybrids as non-peptidomimetic covalent inhibitors targeting 3CLpro protease (3-Chymotrypsin-like Protease).
AbstractList •New ursane hybrids with tetrazole and 5-aminothiatriazoles were synthesized.•New compounds were tested in vitro for SARS-CoV-2 3CLpro inhibition.•Hybrids with 1-tetrazol-5-thione inhibited 3CLpro and were non-toxic for Vero cells.•Molecular docking assumed a disulfide bonding between tetrazole-thiol and cysteine of 3CLpro.•The external bonding of triterpenoid is essential for the affinity with the enzyme. A series of new heterocyclic ursane and 28-norursane hybrids − derivatives of 5-amino-1,2,3,4-thiatriazole, 1-tetrazole–5-thione, and 1-tetrazole–5-amines were prepared. Reacting triterpenoids holding NCS groups at different distances from the pentacyclic backbone with hydrazine hydrate resulted in ursane-derived hydrazinecarbothioamides. Subsequent nitrosation afforded terpenoid derivatives of 5-amino-1,2,3,4-thiatriazole. Heterocyclization of amino-thioureas with 3β-acetoxyurs-12-en-28-yl substituent under the action of Hg(OAc)2-NaN3 led to hybrids of 1-tetrazole–5-amines. 1-Tetrazole–5-thiones with different positions of heterocycle relative to the triterpene skeleton were prepared by coupling sodium azide with triterpene isothiocyanates. The activity of the new heterocyclic derivatives as inhibitors of 3CLpro of SARS-CoV-2 was investigated. Remarkable inhibition was observed for the 1-tetrazole-5-thione hybrids of triterpenoids. The highest activity among the studied compounds was provided by the combination of a 1-tetrazole-5-thione moiety at the C(28)H2 group of the ursane frame having a free OH group at the 3-position. Molecular docking assumed the covalent binding of 3CLpro via the formation of a disulfide bond between the thiol groups of the catalytic Cys145 and the tetrazole heterocycle of the new hybrid compounds. The triterpenoid backbone provided multiple external hydrophobic contacts essential for the stability of the complex. The results demonstrate the potential of heterocyclic thione hybrids as non-peptidomimetic covalent inhibitors targeting 3CLpro protease (3-Chymotrypsin-like Protease).
A series of new heterocyclic ursane and 28-norursane hybrids - derivatives of 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines were prepared. Reacting triterpenoids holding NCS groups at different distances from the pentacyclic backbone with hydrazine hydrate resulted in ursane-derived hydrazinecarbothioamides. Subsequent nitrosation afforded terpenoid derivatives of 5-amino-1,2,3,4-thiatriazole. Heterocyclization of amino-thioureas with 3β-acetoxyurs-12-en-28-yl substituent under the action of Hg(OAc)2-NaN3 led to hybrids of 1-tetrazole-5-amines. 1-Tetrazole-5-thiones with different positions of heterocycle relative to the triterpene skeleton were prepared by coupling sodium azide with triterpene isothiocyanates. The activity of the new heterocyclic derivatives as inhibitors of 3CLpro of SARS-CoV-2 was investigated. Remarkable inhibition was observed for the 1-tetrazole-5-thione hybrids of triterpenoids. The highest activity among the studied compounds was provided by the combination of a 1-tetrazole-5-thione moiety at the C(28)H2 group of the ursane frame having a free OH group at the 3-position. Molecular docking assumed the covalent binding of 3CLpro via the formation of a disulfide bond between the thiol groups of the catalytic Cys145 and the tetrazole heterocycle of the new hybrid compounds. The triterpenoid backbone provided multiple external hydrophobic contacts essential for the stability of the complex. The results demonstrate the potential of heterocyclic thione hybrids as non-peptidomimetic covalent inhibitors targeting 3CLpro protease (3-Chymotrypsin-like Protease).A series of new heterocyclic ursane and 28-norursane hybrids - derivatives of 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines were prepared. Reacting triterpenoids holding NCS groups at different distances from the pentacyclic backbone with hydrazine hydrate resulted in ursane-derived hydrazinecarbothioamides. Subsequent nitrosation afforded terpenoid derivatives of 5-amino-1,2,3,4-thiatriazole. Heterocyclization of amino-thioureas with 3β-acetoxyurs-12-en-28-yl substituent under the action of Hg(OAc)2-NaN3 led to hybrids of 1-tetrazole-5-amines. 1-Tetrazole-5-thiones with different positions of heterocycle relative to the triterpene skeleton were prepared by coupling sodium azide with triterpene isothiocyanates. The activity of the new heterocyclic derivatives as inhibitors of 3CLpro of SARS-CoV-2 was investigated. Remarkable inhibition was observed for the 1-tetrazole-5-thione hybrids of triterpenoids. The highest activity among the studied compounds was provided by the combination of a 1-tetrazole-5-thione moiety at the C(28)H2 group of the ursane frame having a free OH group at the 3-position. Molecular docking assumed the covalent binding of 3CLpro via the formation of a disulfide bond between the thiol groups of the catalytic Cys145 and the tetrazole heterocycle of the new hybrid compounds. The triterpenoid backbone provided multiple external hydrophobic contacts essential for the stability of the complex. The results demonstrate the potential of heterocyclic thione hybrids as non-peptidomimetic covalent inhibitors targeting 3CLpro protease (3-Chymotrypsin-like Protease).
A series of new heterocyclic ursane and 28-norursane hybrids - derivatives of 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines were prepared. Reacting triterpenoids holding NCS groups at different distances from the pentacyclic backbone with hydrazine hydrate resulted in ursane-derived hydrazinecarbothioamides. Subsequent nitrosation afforded terpenoid derivatives of 5-amino-1,2,3,4-thiatriazole. Heterocyclization of amino-thioureas with 3β-acetoxyurs-12-en-28-yl substituent under the action of Hg(OAc) -NaN led to hybrids of 1-tetrazole-5-amines. 1-Tetrazole-5-thiones with different positions of heterocycle relative to the triterpene skeleton were prepared by coupling sodium azide with triterpene isothiocyanates. The activity of the new heterocyclic derivatives as inhibitors of 3CLpro of SARS-CoV-2 was investigated. Remarkable inhibition was observed for the 1-tetrazole-5-thione hybrids of triterpenoids. The highest activity among the studied compounds was provided by the combination of a 1-tetrazole-5-thione moiety at the C(28)H group of the ursane frame having a free OH group at the 3-position. Molecular docking assumed the covalent binding of 3CLpro via the formation of a disulfide bond between the thiol groups of the catalytic Cys145 and the tetrazole heterocycle of the new hybrid compounds. The triterpenoid backbone provided multiple external hydrophobic contacts essential for the stability of the complex. The results demonstrate the potential of heterocyclic thione hybrids as non-peptidomimetic covalent inhibitors targeting 3CLpro protease (3-Chymotrypsin-like Protease).
ArticleNumber 109638
Author Popov, Sergey A.
Pokrovsky, Mikhail.A.
Belenkaya, Svetlana V.
Chirkova, Varvara Yu
Shults, Elvira E.
Volosnikova, Ekaterina A.
Baev, Dmitry S.
Shcherbakov, Dmitry N.
Pokrovsky, Andrey G.
Hamad, Mohammad S.
Author_xml – sequence: 1
  givenname: Sergey A.
  surname: Popov
  fullname: Popov, Sergey A.
  email: spopov@nioch.nsc.ru
  organization: Novosibirsk Institute of Organic Chemistry, Acad. Lavrentyev ave. 9, Novosibirsk 630090, Russia
– sequence: 2
  givenname: Elvira E.
  surname: Shults
  fullname: Shults, Elvira E.
  organization: Novosibirsk Institute of Organic Chemistry, Acad. Lavrentyev ave. 9, Novosibirsk 630090, Russia
– sequence: 3
  givenname: Dmitry S.
  surname: Baev
  fullname: Baev, Dmitry S.
  organization: Novosibirsk Institute of Organic Chemistry, Acad. Lavrentyev ave. 9, Novosibirsk 630090, Russia
– sequence: 4
  givenname: Varvara Yu
  surname: Chirkova
  fullname: Chirkova, Varvara Yu
  organization: Institute of Biology and Biotechnology, Altay State University, 656049 Barnaul, Russia
– sequence: 5
  givenname: Ekaterina A.
  surname: Volosnikova
  fullname: Volosnikova, Ekaterina A.
  organization: State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559 Koltsovo, Russia
– sequence: 6
  givenname: Svetlana V.
  surname: Belenkaya
  fullname: Belenkaya, Svetlana V.
  organization: State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559 Koltsovo, Russia
– sequence: 7
  givenname: Dmitry N.
  surname: Shcherbakov
  fullname: Shcherbakov, Dmitry N.
  organization: Institute of Biology and Biotechnology, Altay State University, 656049 Barnaul, Russia
– sequence: 8
  givenname: Mikhail.A.
  surname: Pokrovsky
  fullname: Pokrovsky, Mikhail.A.
  organization: Novosibirsk State University, Pirogova St. 1, Novosibirsk 630090, Russia
– sequence: 9
  givenname: Mohammad S.
  surname: Hamad
  fullname: Hamad, Mohammad S.
  organization: Novosibirsk State University, Pirogova St. 1, Novosibirsk 630090, Russia
– sequence: 10
  givenname: Andrey G.
  surname: Pokrovsky
  fullname: Pokrovsky, Andrey G.
  organization: Novosibirsk State University, Pirogova St. 1, Novosibirsk 630090, Russia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40409429$$D View this record in MEDLINE/PubMed
BookMark eNqFUU1vFCEYJqbGbqt_oeHoYVhhgBm42Wy0mjQxsdZ4IwzzTobNzlCBrVl_Sn-tTLf14MUT4X0-XnieM3QyhxkQumB0zShr3m3XKUMMvk_rmtayDHXD1Qu0YqpVRKqmPUErSrkmrFY_TtFZSltKacN1_QqdCiqoFrVeoYfbmOwMeDx0sZjhXz6PWBI7-TkQVtUVrwTJo7c5evs77KDCjGTI8fFC5IKVl1XYzv0_yOIB6RFIed8fcBhwHsFH7OfRdz4X4TKbrJ_xzeXXG7IJ30mN72LIYBO8Ri8Hu0vw5uk8R7cfP3zbfCLXX64-by6vieOszaSXVg0dtBo448IpC84qJWpQquNNL2lXCB0dhFSubYBppXsphRYtaEFbx8_R26NvWfxzDymbyScHu13JJeyT4TVtS8YtlYV68UTddxP05i76ycaDec6zEJojwcWQUoThL4VRsxRntua5OLMUZ47FFeH7oxDKT-89RJOch9lB7yO4bPrg_2fxB94Qo30
Cites_doi 10.1039/b810300c
10.1021/acs.jctc.1c00302
10.1016/S0065-2725(08)60854-5
10.3390/ijms222111739
10.1016/j.molstruc.2021.131751
10.1016/j.steroids.2019.108524
10.1093/nar/28.1.235
10.1371/journal.pone.0042846
10.1126/science.abl4784
10.1016/j.bioorg.2021.104889
10.1016/j.bmcl.2012.06.080
10.1016/j.ejmech.2024.116788
10.1080/17415993.2023.2193669
10.1007/s00044-016-1680-1
10.1023/A:1015387108748
10.3390/v13040609
10.1016/j.ejmech.2019.05.071
10.3390/ph15060744
10.1021/acsptsci.0c00130
10.2174/138955709788681618
10.2174/18755348MTEyoMzEFz
10.1135/cccc2009015
10.1007/s10593-021-03001-6
10.1134/S1070428017110185
10.2174/0929867324666171009122612
10.1016/j.ijantimicag.2019.07.015
10.1021/jo01355a601
10.1016/j.crci.2012.12.018
10.1139/v57-116
10.1021/acs.jmedchem.2c01005
10.3390/life12111706
10.1134/S1070363217040119
10.1016/j.ejmech.2023.115491
10.1021/jo00027a038
10.1016/j.bmc.2018.07.025
10.1021/ol006465b
10.1016/S0968-0896(02)00239-0
10.1002/slct.202200706
10.1016/j.bmc.2015.12.048
10.1016/j.antiviral.2013.02.003
10.5012/bkcs.2012.33.1.55
10.1016/j.bmcl.2019.04.028
10.1070/RCR4864
10.1016/j.exppara.2020.107935
10.1007/s10593-024-03350-y
10.1038/s41422-022-00640-y
10.1007/s00894-022-05341-2
10.1139/v59-015
10.1039/C2MD20327H
10.2174/1568026620666201207095117
10.1039/C5NP00015G
10.1016/S0040-4020(01)86975-1
10.1016/j.biopha.2017.07.152
10.1038/srep27403
10.1021/ci500118s
10.1016/j.molstruc.2015.07.017
10.3390/molecules25204604
ContentType Journal Article
Copyright 2025 Elsevier Inc.
Copyright © 2025 Elsevier Inc. All rights reserved.
Copyright © 2025. Published by Elsevier Inc.
Copyright_xml – notice: 2025 Elsevier Inc.
– notice: Copyright © 2025 Elsevier Inc. All rights reserved.
– notice: Copyright © 2025. Published by Elsevier Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.steroids.2025.109638
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1878-5867
ExternalDocumentID 40409429
10_1016_j_steroids_2025_109638
S0039128X25000790
Genre Journal Article
GroupedDBID ---
--K
--M
-~X
.55
.GJ
.~1
0R~
123
1B1
1RT
1~.
1~5
29Q
3O-
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABFNM
ABGSF
ABJNI
ABMAC
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFS
ACIUM
ACKIV
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AFJKZ
AFPUW
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGRNS
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
C45
CS3
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
J5H
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
TEORI
WH7
WUQ
X7M
ZGI
~G-
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c317t-d5a8fbe79e3134c8aeca8842e88b36d50b5a8b0f458c76e1989d554947e9407c3
IEDL.DBID .~1
ISSN 0039-128X
1878-5867
IngestDate Wed Jul 02 02:56:52 EDT 2025
Sat Jun 14 01:31:05 EDT 2025
Thu Jul 03 08:38:15 EDT 2025
Sat Jul 05 17:11:23 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Ursane hybrid
Covalent bonding
SARS-CoV-2 protease
Thione
Tetrazole
Molecular docking
Language English
License Copyright © 2025 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c317t-d5a8fbe79e3134c8aeca8842e88b36d50b5a8b0f458c76e1989d554947e9407c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 40409429
PQID 3207202705
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3207202705
pubmed_primary_40409429
crossref_primary_10_1016_j_steroids_2025_109638
elsevier_sciencedirect_doi_10_1016_j_steroids_2025_109638
PublicationCentury 2000
PublicationDate 2025-08-01
PublicationDateYYYYMMDD 2025-08-01
PublicationDate_xml – month: 08
  year: 2025
  text: 2025-08-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Steroids
PublicationTitleAlternate Steroids
PublicationYear 2025
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Holm (b0265) 1976; 20
van de Sand, Bormann, Alt, Schipper, Heilingloh, Steinmann, Todt, Dittmer, Elsner, Witzke, Krawczyk (b0045) 2021; 13
Popov, Qi, Wang, Shults (b0180) 2023
La Monica, Bono, Lauria, Martorana (b0285) 2022; 65
Popova, Trifonov, Ostrovskii (b0060) 2019; 88
Popov, Semenova, Baev, Frolova, Shults, Wang, Turks (b0270) 2020; 153
Leyva-ramos, Cardoso-ortiz (b0055) 2021
Sabbah, Hajjo, Bardaweel, Zhong (b0010) 2021; 21
Alam, Nami, Husain, Lee, Park (b0115) 2013; 16
Vishwakarma, Gadipelly, Mannepalli (b0070) 2022; 7
Sudhakar, Rajaram, Ramaiah, Rao, Ramraj (b0145) 1987; 64
Zhu, Borrelli, Greenwood, Day, Abel, Farid, Harder (b0215) 2014; 54
Pokorny, Borkova, Urban (b0125) 2018; 25
Kuczynska, Bończak, Rárová, Kvasnicová, Strnad, Pakulski, Cmoch, Fiałkowski (b0135) 2022; 1250
Schrodinger small molecule drug discovery suite, Schrödinger, (2022) LLC, New York.
Sacco, Hu, Gongora, Meilleur, Kemp, Zhang, Wang, Chen (b0210) 2022; 32
Zhang, Jin, Liu, Jin, Jin, Wei (b0155) 2020; 216
Suenaga, Okimoto, Hirano, Fukui (b0220) 2012; 7
Zhang, Wang, Ba, Xu (b0165) 2019; 178
Petrova, Poptsov, Thu, Van Tuyen, Khusnutdinova, Babkov, Kazakova (b0130) 2021; 57
Ma, Hu, Townsend, Lagarias, Marty, Kolocouris, Wang (b0310) 2020; 3
Silva, Freitas, Campos, Kimani, Silva, Borges, Pita, Santos (b0020) 2021; 22
Tohmé, Giménez, Peralta, Colombo, Delgui (b0035) 2019; 54
Shcherbakov, Baev, Kalinin, Dalinger, Chirkova, Belenkaya, Khvostov, Krut’Ko, Medved’Ko, Volosnikova, Sharlaeva, Shanshin, Tolstikova, Yarovaya, Maksyutov, Salakhutdinov, Vatsadze (b0190) 2021
Myznikov, Vorona, Artamonova, Zevatskii (b0255) 2017; 87
Kvasnica, Urban, Dickinson, Sarek (b0120) 2015; 32
Alam, Alam, Nami, Khan, Ahmad, Lee (b0100) 2015; 1099
Popov, Shults, Shpatov, Semenova (b0275) 2024; 60
Pang, Xu, Liu, Li, Chen (b0280) 2023; 257
Zhang, Zhang, Li, Wei, Jin, Piao (b0150) 2019; 29
Meewan, Kattoula, Kattoula, Skinner, Fajtová, Giardini, Woodworth, McKerrow, Lage de Siqueira-Neto, O’donoghue, Abagyan (b0300) 2022; 15
Timilsina, Ghimire, Timalsina, Nitz, Wild, Freed, Gaur (b0050) 2016; 6
Batey, Powell (b0260) 2000; 2
Sun, Chen, Su, Li, Jiang, Gao, Chigan, Ding, Zhai, Yang (b0295) 2021; 112
Herr (b0065) 2002; 10
Zhan, Li, Liu, De Clercq (b0090) 2009; 9
Lu, Wu, Ghoreishi, Chen, Wang, Damm, Ross, Dahlgren, Russell, Von Bargen, Abel, Friesner, Harder (b0200) 2021; 17
Nogara, Omage, Bolzan, Delgado, Orian, Rocha (b0305) 2022; 28
Aggarwal, Mahapatra, Kumar, Bhardwaj, Hartmann, Haupenthal, Kumar (b0110) 2016; 24
Singh, Gautam, Chandel, Ghosh, Dey, Roy, Ravichandiran, Ghosh (b0025) 2020; 25
Bielenica, Szulczyk, Olejarz, Madeddu, Giliberti, Materek, Koziol, Struga (b0080) 2017; 94
Popova, Protas, Trifonov (b0095) 2017; 17
Hrabálek, Pus, Baranek, Kunes, Palat (b0240) 2002; 38
Han, Lee, Kim, Kim, Lee, Gyoung (b0250) 2012; 33
Zhu, Zhang, Lin, Lyu, Lu, Chen, Zhang, Zhang, Chen (b0005) 2023
Zabrocki, Dunbar, Marshall, Toth, Marshall (b0075) 1992; 57
Ren, Anaya-Eugenio, Czarnecki, Ninh, Yuan, Chai, Soejarto, Burdette, de Blanco, Kinghorn (b0175) 2018; 26
Owen, Allerton, Anderson, Aschenbrenner, Avery, Berritt, Boras, Cardin, Carlo, Coffman, Dantonio, Di, Eng, Ferre, Gajiwala, Gibson, Greasley, Hurst, Kadar, Kalgutkar, Lee, Lee, Liu, Mason, Noell, Novak, Obach, Ogilvie, Patel, Pettersson, Rai, Reese, Sammons, Sathish, Singh, Steppan, Stewart, Tuttle, Updyke, Verhoest, Wei, Yang, Zhu (b0290) 2021; 374
Lieber, Ramachandran (b0245) 1959; 37
Kong, Li, Liao, Zhang, Sun, Zhu, Zhang, Wang, Wu, Fang, Zhu (b0040) 2013; 98
Zorina, Kaledina, Motsepuro, Anokhina, Marchenko, Selivanov, Zarubaev, Trifonov (b0085) 2017; 53
Berman (b0205) 2000; 28
Tkachev, Denisov (b0170) 1994; 50
Lieber, Oftedahl, Pillai, Hites (b0225) 1957; 22
Katritzky, Meher, Narindoshvili (b0235) 2009; 74
He, Liang, Shen, Zhang, Liu, Yang, Liu, Wang, Xie, Hu, Song, Wang (b0030) 2022; 12
Jourdan, Bubert, Leese, Smith, Ferrandis, Regis-Lydi, Newman, Purohit, Reed, Potter (b0160) 2008; 6
Liu, Yang, Jin, Hu, Xue, Yang (b0185) 2016; 25
Dang, Qian, Ho, Zhu, Lee, Huang, Chen (b0140) 2012; 22
Penov-Gaši, Oklješa, Petri, Ćelić, Djurendić, Klisurić, Csanadi, Batta, Nikolić, Jakimov, Sakač (b0105) 2013; 4
Liu (b0015) 2024; 278
Lieber, Pillai, Hites (b0230) 1957; 35
Holm (10.1016/j.steroids.2025.109638_b0265) 1976; 20
Pokorny (10.1016/j.steroids.2025.109638_b0125) 2018; 25
Aggarwal (10.1016/j.steroids.2025.109638_b0110) 2016; 24
Dang (10.1016/j.steroids.2025.109638_b0140) 2012; 22
Popov (10.1016/j.steroids.2025.109638_b0180) 2023
Sacco (10.1016/j.steroids.2025.109638_b0210) 2022; 32
10.1016/j.steroids.2025.109638_b0195
Meewan (10.1016/j.steroids.2025.109638_b0300) 2022; 15
Tohmé (10.1016/j.steroids.2025.109638_b0035) 2019; 54
Alam (10.1016/j.steroids.2025.109638_b0115) 2013; 16
Kong (10.1016/j.steroids.2025.109638_b0040) 2013; 98
He (10.1016/j.steroids.2025.109638_b0030) 2022; 12
Zhu (10.1016/j.steroids.2025.109638_b0005) 2023
Singh (10.1016/j.steroids.2025.109638_b0025) 2020; 25
Owen (10.1016/j.steroids.2025.109638_b0290) 2021; 374
Sun (10.1016/j.steroids.2025.109638_b0295) 2021; 112
Nogara (10.1016/j.steroids.2025.109638_b0305) 2022; 28
Lieber (10.1016/j.steroids.2025.109638_b0230) 1957; 35
Han (10.1016/j.steroids.2025.109638_b0250) 2012; 33
Petrova (10.1016/j.steroids.2025.109638_b0130) 2021; 57
Lieber (10.1016/j.steroids.2025.109638_b0225) 1957; 22
Herr (10.1016/j.steroids.2025.109638_b0065) 2002; 10
Katritzky (10.1016/j.steroids.2025.109638_b0235) 2009; 74
Zhang (10.1016/j.steroids.2025.109638_b0165) 2019; 178
Zhu (10.1016/j.steroids.2025.109638_b0215) 2014; 54
Suenaga (10.1016/j.steroids.2025.109638_b0220) 2012; 7
Popov (10.1016/j.steroids.2025.109638_b0270) 2020; 153
Popova (10.1016/j.steroids.2025.109638_b0095) 2017; 17
Shcherbakov (10.1016/j.steroids.2025.109638_b0190) 2021
Popov (10.1016/j.steroids.2025.109638_b0275) 2024; 60
Kuczynska (10.1016/j.steroids.2025.109638_b0135) 2022; 1250
van de Sand (10.1016/j.steroids.2025.109638_b0045) 2021; 13
Popova (10.1016/j.steroids.2025.109638_b0060) 2019; 88
Lieber (10.1016/j.steroids.2025.109638_b0245) 1959; 37
Zorina (10.1016/j.steroids.2025.109638_b0085) 2017; 53
La Monica (10.1016/j.steroids.2025.109638_b0285) 2022; 65
Jourdan (10.1016/j.steroids.2025.109638_b0160) 2008; 6
Liu (10.1016/j.steroids.2025.109638_b0015) 2024; 278
Kvasnica (10.1016/j.steroids.2025.109638_b0120) 2015; 32
Sudhakar (10.1016/j.steroids.2025.109638_b0145) 1987; 64
Myznikov (10.1016/j.steroids.2025.109638_b0255) 2017; 87
Batey (10.1016/j.steroids.2025.109638_b0260) 2000; 2
Vishwakarma (10.1016/j.steroids.2025.109638_b0070) 2022; 7
Zabrocki (10.1016/j.steroids.2025.109638_b0075) 1992; 57
Liu (10.1016/j.steroids.2025.109638_b0185) 2016; 25
Berman (10.1016/j.steroids.2025.109638_b0205) 2000; 28
Sabbah (10.1016/j.steroids.2025.109638_b0010) 2021; 21
Tkachev (10.1016/j.steroids.2025.109638_b0170) 1994; 50
Leyva-ramos (10.1016/j.steroids.2025.109638_b0055) 2021
Alam (10.1016/j.steroids.2025.109638_b0100) 2015; 1099
Zhan (10.1016/j.steroids.2025.109638_b0090) 2009; 9
Lu (10.1016/j.steroids.2025.109638_b0200) 2021; 17
Penov-Gaši (10.1016/j.steroids.2025.109638_b0105) 2013; 4
Zhang (10.1016/j.steroids.2025.109638_b0155) 2020; 216
Ma (10.1016/j.steroids.2025.109638_b0310) 2020; 3
Silva (10.1016/j.steroids.2025.109638_b0020) 2021; 22
Zhang (10.1016/j.steroids.2025.109638_b0150) 2019; 29
Hrabálek (10.1016/j.steroids.2025.109638_b0240) 2002; 38
Bielenica (10.1016/j.steroids.2025.109638_b0080) 2017; 94
Ren (10.1016/j.steroids.2025.109638_b0175) 2018; 26
Pang (10.1016/j.steroids.2025.109638_b0280) 2023; 257
Timilsina (10.1016/j.steroids.2025.109638_b0050) 2016; 6
References_xml – volume: 57
  start-page: 202
  year: 1992
  end-page: 209
  ident: b0075
  article-title: Conformational mimicry. 3. Synthesis and incorporation of 1, 5-disubstituted tetrazole dipeptide analogs into peptides with preservation of chiral integrity: bradykinin
  publication-title: J. Org. Chem.
– volume: 22
  start-page: 11739
  year: 2021
  ident: b0020
  article-title: Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro
  publication-title: Int. J. Mol. Sci.
– volume: 257
  year: 2023
  ident: b0280
  article-title: The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022
  publication-title: Eur. J. Med. Chem.
– volume: 28
  start-page: 1
  year: 2022
  end-page: 12
  ident: b0305
  article-title: Reactivity and binding mode of disulfiram, its metabolites, and derivatives in SARS-CoV-2 PLpro: insights from computational chemistry studies
  publication-title: J. Mol. Model
– volume: 6
  start-page: 4108
  year: 2008
  end-page: 4119
  ident: b0160
  article-title: Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1, 3, 5 (10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling
  publication-title: Org. Biomol. Chem.
– volume: 87
  start-page: 731
  year: 2017
  end-page: 738
  ident: b0255
  article-title: Mechanism of the zinc-catalyzed addition of azide ion to unsaturated compounds : Synthesis of 5-substituted 1 H -tetrazoles from nitriles and of 1-substituted 1 H -tetrazole-5-thiols from isothiocyanates
  publication-title: Russ. J. Gen. Chem.
– volume: 17
  start-page: 4291
  year: 2021
  end-page: 4300
  ident: b0200
  article-title: OPLS4: Improving force field accuracy on challenging regimes of chemical space
  publication-title: J. Chem. Theory Comput.
– volume: 9
  start-page: 1014
  year: 2009
  end-page: 1023
  ident: b0090
  article-title: Sulfanyltriazole/tetrazoles: a promising class of HIV-1 NNRTIs
  publication-title: Mini Rev. Med. Chem.
– volume: 28
  start-page: 235
  year: 2000
  end-page: 242
  ident: b0205
  article-title: The protein data bank
  publication-title: Nucleic Acids Res.
– volume: 22
  start-page: 5190
  year: 2012
  end-page: 5194
  ident: b0140
  article-title: Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants
  publication-title: Bioorg. Med. Chem. Lett.
– volume: 32
  start-page: 498
  year: 2022
  end-page: 500
  ident: b0210
  article-title: The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition
  publication-title: Cell Res.
– volume: 15
  year: 2022
  ident: b0300
  article-title: Discovery of triple inhibitors of both SARS-CoV-2 proteases and human cathepsin L
  publication-title: Pharmaceuticals
– volume: 1250
  year: 2022
  ident: b0135
  article-title: Synthesis and cytotoxic activity of 1,2,3-triazoles derived from 2,3-seco-dihydrobetulin via a click chemistry approach
  publication-title: J. Mol. Struct.
– volume: 64
  start-page: 712
  year: 1987
  end-page: 713
  ident: b0145
  article-title: Azatriterpenes. 7. Synthesis of 2-eno-[2, 3-g] tetrazolo [1, 5-a] pyrimidines of pentacyclic triterpenes
  publication-title: J. Indian Chem. Soc.
– volume: 24
  start-page: 779
  year: 2016
  end-page: 788
  ident: b0110
  article-title: Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitors
  publication-title: Bioorg. Med. Chem.
– volume: 38
  start-page: 183
  year: 2002
  end-page: 189
  ident: b0240
  article-title: Synthesis of unsymmetrical sulfides derived from tetrazole-5-thiols
  publication-title: Chem. Heterocycl. Compd.
– volume: 7
  year: 2022
  ident: b0070
  article-title: Advances in Tetrazole Synthesis – An Overview
  publication-title: ChemistrySelect
– start-page: 523
  year: 2023
  end-page: 541
  ident: b0180
  article-title: Synthesis of ursane-derived isothiocyanates and study of their reactions with series of amines and ammonia
  publication-title: J. Sulfur Chem.
– volume: 26
  start-page: 4452
  year: 2018
  end-page: 4460
  ident: b0175
  article-title: Cytotoxic and NF-κB and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives
  publication-title: Bioorg. Med. Chem.
– volume: 7
  year: 2012
  ident: b0220
  article-title: An efficient computational method for calculating ligand binding affinities
  publication-title: PLoS One
– volume: 98
  start-page: 44
  year: 2013
  end-page: 53
  ident: b0040
  article-title: Oleanolic acid and ursolic acid: Novel hepatitis C virus antivirals that inhibit NS5B activity
  publication-title: Antiviral Res.
– year: 2021
  ident: b0190
  article-title: Design and evaluation of bispidine-based SARS-CoV-2 main protease inhibitors, ACS Med
  publication-title: Chem. Lett.
– volume: 112
  year: 2021
  ident: b0295
  article-title: Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals
  publication-title: Bioorg. Chem.
– start-page: 388
  year: 2021
  end-page: 403
  ident: b0055
  article-title: Recent developments in the synthesis of tetrazoles and their pharmacological relevance
  publication-title: Curr. Org. Chem.
– volume: 21
  start-page: 442
  year: 2021
  end-page: 460
  ident: b0010
  article-title: An updated review on SARS-CoV-2 main proteinase (MPro): protein structure and small-molecule inhibitors
  publication-title: Curr. Top. Med. Chem.
– volume: 94
  start-page: 804
  year: 2017
  end-page: 812
  ident: b0080
  article-title: 1H-Tetrazol-5-amine and 1, 3-thiazolidin-4-one derivatives containing 3-(trifluoromethyl) phenyl scaffold: Synthesis, cytotoxic and anti-HIV studies
  publication-title: Biomed. Pharmacother.
– volume: 54
  start-page: 1932
  year: 2014
  end-page: 1940
  ident: b0215
  article-title: Docking covalent inhibitors: A parameter free approach to pose prediction and scoring
  publication-title: J. Chem. Inf. Model.
– volume: 37
  start-page: 101
  year: 1959
  end-page: 109
  ident: b0245
  article-title: Isomeric 5-(substituted) aminothiatriazole and 1-substituted-tetrazolinethiones
  publication-title: Can. J. Chem.
– volume: 6
  start-page: 27403
  year: 2016
  ident: b0050
  article-title: Identification of potent maturation inhibitors against HIV-1 clade C
  publication-title: Sci. Rep.
– volume: 74
  start-page: 1061
  year: 2009
  end-page: 1068
  ident: b0235
  article-title: Convenient one-pot synthesis of 5-(substituted amino)-1, 2, 3, 4-thiatriazoles
  publication-title: Collect. Czechoslov. Chem. Commun.
– volume: 13
  start-page: 609
  year: 2021
  ident: b0045
  article-title: Glycyrrhizin effectively inhibits SARS-CoV-2 replication by inhibiting the viral main protease
  publication-title: Viruses
– volume: 32
  start-page: 1303
  year: 2015
  end-page: 1330
  ident: b0120
  article-title: Pentacyclic triterpenoids with nitrogen- and sulfur-containing heterocycles: Synthesis and medicinal significance
  publication-title: Nat. Prod. Rep.
– volume: 57
  start-page: 920
  year: 2021
  end-page: 928
  ident: b0130
  article-title: Synthesis, cytotoxicity, and α-glucosidase inhibitory activity of triterpenic and sitosterol tetrazole derivatives
  publication-title: Chem. Heterocycl. Compd.
– volume: 25
  start-page: 636
  year: 2018
  end-page: 658
  ident: b0125
  article-title: Click reactions in chemistry of triterpenes - advances towards development of potential therapeutics
  publication-title: Curr. Med. Chem.
– volume: 1099
  start-page: 588
  year: 2015
  end-page: 600
  ident: b0100
  article-title: DFT, Hirshfeld surfaces, spectral and in vivo cytotoxic studies of 7a-Aza-B-homostigmast-5-eno [7a, 7-d] tetrazole
  publication-title: J. Mol. Struct.
– volume: 374
  start-page: 1586
  year: 2021
  end-page: 1593
  ident: b0290
  article-title: An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
  publication-title: Science
– volume: 25
  start-page: 4604
  year: 2020
  ident: b0025
  article-title: Protease inhibitory effect of natural polyphenolic compounds on SARS-CoV-2: an in silico study
  publication-title: Molecules
– volume: 25
  start-page: 2267
  year: 2016
  end-page: 2279
  ident: b0185
  article-title: Synthesis and evaluation as potential antitumor agents of novel ursolic acid derivatives
  publication-title: Med. Chem. Res.
– volume: 153
  year: 2020
  ident: b0270
  article-title: Synthesis of cytotoxic urs-12-ene-and 28-norurs-12-ene-type conjugates with amino-and mercapto-1, 3, 4-oxadiazoles and mercapto-1, 2, 4-triazoles
  publication-title: Steroids
– volume: 33
  start-page: 55
  year: 2012
  end-page: 59
  ident: b0250
  article-title: A facile one-pot synthesis of 1-substituted tetrazole-5-thiones and 1-substituted 5-alkyl(aryl)sulfanyltetrazoles from organic isothiocyanates
  publication-title: Bull. Korean Chem. Soc.
– volume: 20
  start-page: 145
  year: 1976
  end-page: 174
  ident: b0265
  article-title: 1, 2, 3, 4-Thiatriazoles
  publication-title: Adv. Heterocycl. Chem.
– volume: 278
  year: 2024
  ident: b0015
  article-title: How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents
  publication-title: Eur. J. Med. Chem.
– volume: 60
  start-page: 377
  year: 2024
  end-page: 389
  ident: b0275
  article-title: Synthesis of ursane-derived regioisomeric 2-amino-1, 3, 4-oxadiazoles and 3-thioxo-1, 2, 4-triazoles
  publication-title: Chem. Heterocycl. Compd.
– volume: 12
  start-page: 1706
  year: 2022
  ident: b0030
  article-title: Glycyrrhizin inhibits SARS-CoV-2 entry into cells by targeting ACE2
  publication-title: Life
– volume: 17
  start-page: 1856
  year: 2017
  end-page: 1868
  ident: b0095
  article-title: Tetrazole derivatives as promising anticancer agents, Anti-Cancer Agents Med
  publication-title: Chem. (formerly Curr. Med. Chem. Agents)
– start-page: 1067
  year: 2023
  end-page: 1082
  ident: b0005
  article-title: Progress on SARS-CoV-2 3CLpro inhibitors: inspiration from SARS-CoV 3CLpro peptidomimetics and small-molecule anti-inflammatory compounds
  publication-title: Drug Des. Devel. Ther.
– volume: 4
  start-page: 317
  year: 2013
  end-page: 323
  ident: b0105
  article-title: Selective antitumour activity and ERα molecular docking studies of newly synthesized D-homo fused steroidal tetrazoles
  publication-title: Medchemcomm.
– volume: 29
  start-page: 1440
  year: 2019
  end-page: 1445
  ident: b0150
  article-title: Synthesis and evaluation of the HIF-1α inhibitory activities of novel ursolic acid tetrazole derivatives
  publication-title: Bioorg. Med. Chem. Lett.
– volume: 178
  start-page: 341
  year: 2019
  end-page: 351
  ident: b0165
  article-title: Tetrazole hybrids with potential anticancer activity
  publication-title: Eur. J. Med. Chem.
– volume: 22
  start-page: 441
  year: 1957
  end-page: 442
  ident: b0225
  article-title: Infrared spectrum of the so-called 5-amino 1, 2, 3, 4-thiatriazole
  publication-title: J. Org. Chem.
– volume: 88
  start-page: 644
  year: 2019
  end-page: 676
  ident: b0060
  article-title: Tetrazoles for biomedicine
  publication-title: Russ. Chem. Rev.
– volume: 50
  start-page: 2591
  year: 1994
  end-page: 2598
  ident: b0170
  article-title: Oxidative decarboxylation by hydrogen peroxide and a mercury (II) salt: A simple route to nor-derivatives of acetyloleanolic, acetylursolic and dehydroabietic acids
  publication-title: Tetrahedron
– volume: 2
  start-page: 3237
  year: 2000
  end-page: 3240
  ident: b0260
  article-title: A general synthetic method for the formation of substituted 5-aminotetrazoles from thioureas: A strategy for diversity amplification
  publication-title: Org. Lett.
– volume: 35
  start-page: 832
  year: 1957
  end-page: 842
  ident: b0230
  article-title: The reaction of nitrous acid with 4-substituted-thiosemicarbazides
  publication-title: Can. J. Chem.
– volume: 16
  start-page: 201
  year: 2013
  end-page: 206
  ident: b0115
  article-title: Synthesis, characterization, X-ray diffraction, antimicrobial and in vitro cytotoxicity studies of 7a-Aza-B-homostigmast-5-eno [7a, 7-d] tetrazole
  publication-title: Comptes Rendus Chim.
– volume: 53
  start-page: 1710
  year: 2017
  end-page: 1716
  ident: b0085
  article-title: Synthesis and anti-influenza activity of 2-cyanoethoxy and 2-(1H-tetrazol-5-yl)ethoxy derivatives of dammarane-type triterpenoids
  publication-title: Russ. J. Org. Chem.
– volume: 3
  start-page: 1265
  year: 2020
  end-page: 1277
  ident: b0310
  article-title: Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are nonspecific promiscuous SARS-CoV-2 main protease inhibitors
  publication-title: ACS Pharmacol. Transl. Sci.
– volume: 54
  start-page: 601
  year: 2019
  end-page: 609
  ident: b0035
  article-title: Ursolic acid: A novel antiviral compound inhibiting rotavirus infection in vitro
  publication-title: Int. J. Antimicrob. Agents
– volume: 10
  start-page: 3379
  year: 2002
  end-page: 3393
  ident: b0065
  article-title: 5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods
  publication-title: Bioorg. Med. Chem.
– volume: 216
  year: 2020
  ident: b0155
  article-title: Evaluation of ursolic acid derivatives with potential anti-Toxoplasma gondii activity
  publication-title: Exp. Parasitol.
– volume: 65
  start-page: 12500
  year: 2022
  end-page: 12534
  ident: b0285
  article-title: Targeting SARS-CoV-2 main protease for treatment of COVID-19: Covalent inhibitors structure-activity relationship insights and evolution perspectives
  publication-title: J. Med. Chem.
– reference: Schrodinger small molecule drug discovery suite, Schrödinger, (2022) LLC, New York.
– volume: 6
  start-page: 4108
  year: 2008
  ident: 10.1016/j.steroids.2025.109638_b0160
  article-title: Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1, 3, 5 (10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling
  publication-title: Org. Biomol. Chem.
  doi: 10.1039/b810300c
– volume: 17
  start-page: 4291
  year: 2021
  ident: 10.1016/j.steroids.2025.109638_b0200
  article-title: OPLS4: Improving force field accuracy on challenging regimes of chemical space
  publication-title: J. Chem. Theory Comput.
  doi: 10.1021/acs.jctc.1c00302
– volume: 20
  start-page: 145
  year: 1976
  ident: 10.1016/j.steroids.2025.109638_b0265
  article-title: 1, 2, 3, 4-Thiatriazoles
  publication-title: Adv. Heterocycl. Chem.
  doi: 10.1016/S0065-2725(08)60854-5
– volume: 22
  start-page: 11739
  year: 2021
  ident: 10.1016/j.steroids.2025.109638_b0020
  article-title: Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms222111739
– volume: 1250
  year: 2022
  ident: 10.1016/j.steroids.2025.109638_b0135
  article-title: Synthesis and cytotoxic activity of 1,2,3-triazoles derived from 2,3-seco-dihydrobetulin via a click chemistry approach
  publication-title: J. Mol. Struct.
  doi: 10.1016/j.molstruc.2021.131751
– volume: 153
  year: 2020
  ident: 10.1016/j.steroids.2025.109638_b0270
  article-title: Synthesis of cytotoxic urs-12-ene-and 28-norurs-12-ene-type conjugates with amino-and mercapto-1, 3, 4-oxadiazoles and mercapto-1, 2, 4-triazoles
  publication-title: Steroids
  doi: 10.1016/j.steroids.2019.108524
– volume: 28
  start-page: 235
  year: 2000
  ident: 10.1016/j.steroids.2025.109638_b0205
  article-title: The protein data bank
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/28.1.235
– volume: 7
  year: 2012
  ident: 10.1016/j.steroids.2025.109638_b0220
  article-title: An efficient computational method for calculating ligand binding affinities
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0042846
– year: 2021
  ident: 10.1016/j.steroids.2025.109638_b0190
  article-title: Design and evaluation of bispidine-based SARS-CoV-2 main protease inhibitors, ACS Med
  publication-title: Chem. Lett.
– volume: 374
  start-page: 1586
  year: 2021
  ident: 10.1016/j.steroids.2025.109638_b0290
  article-title: An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
  publication-title: Science
  doi: 10.1126/science.abl4784
– volume: 112
  year: 2021
  ident: 10.1016/j.steroids.2025.109638_b0295
  article-title: Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals
  publication-title: Bioorg. Chem.
  doi: 10.1016/j.bioorg.2021.104889
– volume: 22
  start-page: 5190
  year: 2012
  ident: 10.1016/j.steroids.2025.109638_b0140
  article-title: Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2012.06.080
– volume: 278
  year: 2024
  ident: 10.1016/j.steroids.2025.109638_b0015
  article-title: How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2024.116788
– start-page: 523
  year: 2023
  ident: 10.1016/j.steroids.2025.109638_b0180
  article-title: Synthesis of ursane-derived isothiocyanates and study of their reactions with series of amines and ammonia
  publication-title: J. Sulfur Chem.
  doi: 10.1080/17415993.2023.2193669
– volume: 25
  start-page: 2267
  year: 2016
  ident: 10.1016/j.steroids.2025.109638_b0185
  article-title: Synthesis and evaluation as potential antitumor agents of novel ursolic acid derivatives
  publication-title: Med. Chem. Res.
  doi: 10.1007/s00044-016-1680-1
– volume: 38
  start-page: 183
  year: 2002
  ident: 10.1016/j.steroids.2025.109638_b0240
  article-title: Synthesis of unsymmetrical sulfides derived from tetrazole-5-thiols
  publication-title: Chem. Heterocycl. Compd.
  doi: 10.1023/A:1015387108748
– volume: 13
  start-page: 609
  year: 2021
  ident: 10.1016/j.steroids.2025.109638_b0045
  article-title: Glycyrrhizin effectively inhibits SARS-CoV-2 replication by inhibiting the viral main protease
  publication-title: Viruses
  doi: 10.3390/v13040609
– volume: 178
  start-page: 341
  year: 2019
  ident: 10.1016/j.steroids.2025.109638_b0165
  article-title: Tetrazole hybrids with potential anticancer activity
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2019.05.071
– volume: 15
  year: 2022
  ident: 10.1016/j.steroids.2025.109638_b0300
  article-title: Discovery of triple inhibitors of both SARS-CoV-2 proteases and human cathepsin L
  publication-title: Pharmaceuticals
  doi: 10.3390/ph15060744
– volume: 3
  start-page: 1265
  year: 2020
  ident: 10.1016/j.steroids.2025.109638_b0310
  article-title: Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are nonspecific promiscuous SARS-CoV-2 main protease inhibitors
  publication-title: ACS Pharmacol. Transl. Sci.
  doi: 10.1021/acsptsci.0c00130
– ident: 10.1016/j.steroids.2025.109638_b0195
– volume: 9
  start-page: 1014
  year: 2009
  ident: 10.1016/j.steroids.2025.109638_b0090
  article-title: Sulfanyltriazole/tetrazoles: a promising class of HIV-1 NNRTIs
  publication-title: Mini Rev. Med. Chem.
  doi: 10.2174/138955709788681618
– start-page: 388
  year: 2021
  ident: 10.1016/j.steroids.2025.109638_b0055
  article-title: Recent developments in the synthesis of tetrazoles and their pharmacological relevance
  publication-title: Curr. Org. Chem.
  doi: 10.2174/18755348MTEyoMzEFz
– volume: 74
  start-page: 1061
  year: 2009
  ident: 10.1016/j.steroids.2025.109638_b0235
  article-title: Convenient one-pot synthesis of 5-(substituted amino)-1, 2, 3, 4-thiatriazoles
  publication-title: Collect. Czechoslov. Chem. Commun.
  doi: 10.1135/cccc2009015
– volume: 57
  start-page: 920
  year: 2021
  ident: 10.1016/j.steroids.2025.109638_b0130
  article-title: Synthesis, cytotoxicity, and α-glucosidase inhibitory activity of triterpenic and sitosterol tetrazole derivatives
  publication-title: Chem. Heterocycl. Compd.
  doi: 10.1007/s10593-021-03001-6
– volume: 53
  start-page: 1710
  year: 2017
  ident: 10.1016/j.steroids.2025.109638_b0085
  article-title: Synthesis and anti-influenza activity of 2-cyanoethoxy and 2-(1H-tetrazol-5-yl)ethoxy derivatives of dammarane-type triterpenoids
  publication-title: Russ. J. Org. Chem.
  doi: 10.1134/S1070428017110185
– volume: 25
  start-page: 636
  year: 2018
  ident: 10.1016/j.steroids.2025.109638_b0125
  article-title: Click reactions in chemistry of triterpenes - advances towards development of potential therapeutics
  publication-title: Curr. Med. Chem.
  doi: 10.2174/0929867324666171009122612
– volume: 54
  start-page: 601
  year: 2019
  ident: 10.1016/j.steroids.2025.109638_b0035
  article-title: Ursolic acid: A novel antiviral compound inhibiting rotavirus infection in vitro
  publication-title: Int. J. Antimicrob. Agents
  doi: 10.1016/j.ijantimicag.2019.07.015
– volume: 22
  start-page: 441
  year: 1957
  ident: 10.1016/j.steroids.2025.109638_b0225
  article-title: Infrared spectrum of the so-called 5-amino 1, 2, 3, 4-thiatriazole
  publication-title: J. Org. Chem.
  doi: 10.1021/jo01355a601
– volume: 16
  start-page: 201
  year: 2013
  ident: 10.1016/j.steroids.2025.109638_b0115
  article-title: Synthesis, characterization, X-ray diffraction, antimicrobial and in vitro cytotoxicity studies of 7a-Aza-B-homostigmast-5-eno [7a, 7-d] tetrazole
  publication-title: Comptes Rendus Chim.
  doi: 10.1016/j.crci.2012.12.018
– volume: 64
  start-page: 712
  year: 1987
  ident: 10.1016/j.steroids.2025.109638_b0145
  article-title: Azatriterpenes. 7. Synthesis of 2-eno-[2, 3-g] tetrazolo [1, 5-a] pyrimidines of pentacyclic triterpenes
  publication-title: J. Indian Chem. Soc.
– volume: 35
  start-page: 832
  year: 1957
  ident: 10.1016/j.steroids.2025.109638_b0230
  article-title: The reaction of nitrous acid with 4-substituted-thiosemicarbazides
  publication-title: Can. J. Chem.
  doi: 10.1139/v57-116
– volume: 65
  start-page: 12500
  year: 2022
  ident: 10.1016/j.steroids.2025.109638_b0285
  article-title: Targeting SARS-CoV-2 main protease for treatment of COVID-19: Covalent inhibitors structure-activity relationship insights and evolution perspectives
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.2c01005
– volume: 12
  start-page: 1706
  year: 2022
  ident: 10.1016/j.steroids.2025.109638_b0030
  article-title: Glycyrrhizin inhibits SARS-CoV-2 entry into cells by targeting ACE2
  publication-title: Life
  doi: 10.3390/life12111706
– volume: 87
  start-page: 731
  year: 2017
  ident: 10.1016/j.steroids.2025.109638_b0255
  article-title: Mechanism of the zinc-catalyzed addition of azide ion to unsaturated compounds : Synthesis of 5-substituted 1 H -tetrazoles from nitriles and of 1-substituted 1 H -tetrazole-5-thiols from isothiocyanates
  publication-title: Russ. J. Gen. Chem.
  doi: 10.1134/S1070363217040119
– start-page: 1067
  year: 2023
  ident: 10.1016/j.steroids.2025.109638_b0005
  article-title: Progress on SARS-CoV-2 3CLpro inhibitors: inspiration from SARS-CoV 3CLpro peptidomimetics and small-molecule anti-inflammatory compounds
  publication-title: Drug Des. Devel. Ther.
– volume: 257
  year: 2023
  ident: 10.1016/j.steroids.2025.109638_b0280
  article-title: The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2023.115491
– volume: 57
  start-page: 202
  year: 1992
  ident: 10.1016/j.steroids.2025.109638_b0075
  article-title: Conformational mimicry. 3. Synthesis and incorporation of 1, 5-disubstituted tetrazole dipeptide analogs into peptides with preservation of chiral integrity: bradykinin
  publication-title: J. Org. Chem.
  doi: 10.1021/jo00027a038
– volume: 26
  start-page: 4452
  year: 2018
  ident: 10.1016/j.steroids.2025.109638_b0175
  article-title: Cytotoxic and NF-κB and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2018.07.025
– volume: 17
  start-page: 1856
  year: 2017
  ident: 10.1016/j.steroids.2025.109638_b0095
  article-title: Tetrazole derivatives as promising anticancer agents, Anti-Cancer Agents Med
  publication-title: Chem. (formerly Curr. Med. Chem. Agents)
– volume: 2
  start-page: 3237
  year: 2000
  ident: 10.1016/j.steroids.2025.109638_b0260
  article-title: A general synthetic method for the formation of substituted 5-aminotetrazoles from thioureas: A strategy for diversity amplification
  publication-title: Org. Lett.
  doi: 10.1021/ol006465b
– volume: 10
  start-page: 3379
  year: 2002
  ident: 10.1016/j.steroids.2025.109638_b0065
  article-title: 5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/S0968-0896(02)00239-0
– volume: 7
  year: 2022
  ident: 10.1016/j.steroids.2025.109638_b0070
  article-title: Advances in Tetrazole Synthesis – An Overview
  publication-title: ChemistrySelect
  doi: 10.1002/slct.202200706
– volume: 24
  start-page: 779
  year: 2016
  ident: 10.1016/j.steroids.2025.109638_b0110
  article-title: Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitors
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2015.12.048
– volume: 98
  start-page: 44
  year: 2013
  ident: 10.1016/j.steroids.2025.109638_b0040
  article-title: Oleanolic acid and ursolic acid: Novel hepatitis C virus antivirals that inhibit NS5B activity
  publication-title: Antiviral Res.
  doi: 10.1016/j.antiviral.2013.02.003
– volume: 33
  start-page: 55
  year: 2012
  ident: 10.1016/j.steroids.2025.109638_b0250
  article-title: A facile one-pot synthesis of 1-substituted tetrazole-5-thiones and 1-substituted 5-alkyl(aryl)sulfanyltetrazoles from organic isothiocyanates
  publication-title: Bull. Korean Chem. Soc.
  doi: 10.5012/bkcs.2012.33.1.55
– volume: 29
  start-page: 1440
  year: 2019
  ident: 10.1016/j.steroids.2025.109638_b0150
  article-title: Synthesis and evaluation of the HIF-1α inhibitory activities of novel ursolic acid tetrazole derivatives
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2019.04.028
– volume: 88
  start-page: 644
  year: 2019
  ident: 10.1016/j.steroids.2025.109638_b0060
  article-title: Tetrazoles for biomedicine
  publication-title: Russ. Chem. Rev.
  doi: 10.1070/RCR4864
– volume: 216
  year: 2020
  ident: 10.1016/j.steroids.2025.109638_b0155
  article-title: Evaluation of ursolic acid derivatives with potential anti-Toxoplasma gondii activity
  publication-title: Exp. Parasitol.
  doi: 10.1016/j.exppara.2020.107935
– volume: 60
  start-page: 377
  year: 2024
  ident: 10.1016/j.steroids.2025.109638_b0275
  article-title: Synthesis of ursane-derived regioisomeric 2-amino-1, 3, 4-oxadiazoles and 3-thioxo-1, 2, 4-triazoles
  publication-title: Chem. Heterocycl. Compd.
  doi: 10.1007/s10593-024-03350-y
– volume: 32
  start-page: 498
  year: 2022
  ident: 10.1016/j.steroids.2025.109638_b0210
  article-title: The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition
  publication-title: Cell Res.
  doi: 10.1038/s41422-022-00640-y
– volume: 28
  start-page: 1
  year: 2022
  ident: 10.1016/j.steroids.2025.109638_b0305
  article-title: Reactivity and binding mode of disulfiram, its metabolites, and derivatives in SARS-CoV-2 PLpro: insights from computational chemistry studies
  publication-title: J. Mol. Model
  doi: 10.1007/s00894-022-05341-2
– volume: 37
  start-page: 101
  year: 1959
  ident: 10.1016/j.steroids.2025.109638_b0245
  article-title: Isomeric 5-(substituted) aminothiatriazole and 1-substituted-tetrazolinethiones
  publication-title: Can. J. Chem.
  doi: 10.1139/v59-015
– volume: 4
  start-page: 317
  year: 2013
  ident: 10.1016/j.steroids.2025.109638_b0105
  article-title: Selective antitumour activity and ERα molecular docking studies of newly synthesized D-homo fused steroidal tetrazoles
  publication-title: Medchemcomm.
  doi: 10.1039/C2MD20327H
– volume: 21
  start-page: 442
  year: 2021
  ident: 10.1016/j.steroids.2025.109638_b0010
  article-title: An updated review on SARS-CoV-2 main proteinase (MPro): protein structure and small-molecule inhibitors
  publication-title: Curr. Top. Med. Chem.
  doi: 10.2174/1568026620666201207095117
– volume: 32
  start-page: 1303
  year: 2015
  ident: 10.1016/j.steroids.2025.109638_b0120
  article-title: Pentacyclic triterpenoids with nitrogen- and sulfur-containing heterocycles: Synthesis and medicinal significance
  publication-title: Nat. Prod. Rep.
  doi: 10.1039/C5NP00015G
– volume: 50
  start-page: 2591
  year: 1994
  ident: 10.1016/j.steroids.2025.109638_b0170
  article-title: Oxidative decarboxylation by hydrogen peroxide and a mercury (II) salt: A simple route to nor-derivatives of acetyloleanolic, acetylursolic and dehydroabietic acids
  publication-title: Tetrahedron
  doi: 10.1016/S0040-4020(01)86975-1
– volume: 94
  start-page: 804
  year: 2017
  ident: 10.1016/j.steroids.2025.109638_b0080
  article-title: 1H-Tetrazol-5-amine and 1, 3-thiazolidin-4-one derivatives containing 3-(trifluoromethyl) phenyl scaffold: Synthesis, cytotoxic and anti-HIV studies
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2017.07.152
– volume: 6
  start-page: 27403
  year: 2016
  ident: 10.1016/j.steroids.2025.109638_b0050
  article-title: Identification of potent maturation inhibitors against HIV-1 clade C
  publication-title: Sci. Rep.
  doi: 10.1038/srep27403
– volume: 54
  start-page: 1932
  year: 2014
  ident: 10.1016/j.steroids.2025.109638_b0215
  article-title: Docking covalent inhibitors: A parameter free approach to pose prediction and scoring
  publication-title: J. Chem. Inf. Model.
  doi: 10.1021/ci500118s
– volume: 1099
  start-page: 588
  year: 2015
  ident: 10.1016/j.steroids.2025.109638_b0100
  article-title: DFT, Hirshfeld surfaces, spectral and in vivo cytotoxic studies of 7a-Aza-B-homostigmast-5-eno [7a, 7-d] tetrazole
  publication-title: J. Mol. Struct.
  doi: 10.1016/j.molstruc.2015.07.017
– volume: 25
  start-page: 4604
  year: 2020
  ident: 10.1016/j.steroids.2025.109638_b0025
  article-title: Protease inhibitory effect of natural polyphenolic compounds on SARS-CoV-2: an in silico study
  publication-title: Molecules
  doi: 10.3390/molecules25204604
SSID ssj0006392
Score 2.4416838
Snippet •New ursane hybrids with tetrazole and 5-aminothiatriazoles were synthesized.•New compounds were tested in vitro for SARS-CoV-2 3CLpro inhibition.•Hybrids with...
A series of new heterocyclic ursane and 28-norursane hybrids - derivatives of 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines were...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 109638
SubjectTerms Amines - chemistry
Amines - pharmacology
Antiviral Agents - chemical synthesis
Antiviral Agents - chemistry
Antiviral Agents - pharmacology
Coronavirus 3C Proteases - antagonists & inhibitors
Coronavirus 3C Proteases - chemistry
Coronavirus 3C Proteases - metabolism
Covalent bonding
COVID-19 Drug Treatment
Humans
Molecular docking
Molecular Docking Simulation
Protease Inhibitors - chemical synthesis
Protease Inhibitors - chemistry
Protease Inhibitors - pharmacology
SARS-CoV-2 - drug effects
SARS-CoV-2 - enzymology
SARS-CoV-2 protease
Tetrazole
Tetrazoles - chemistry
Tetrazoles - pharmacology
Thione
Thiones - chemistry
Thiones - pharmacology
Triterpenes - chemistry
Triterpenes - pharmacology
Ursane hybrid
Title Ursane hybrids with 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines and study of their inhibition of main SARS-CoV-2 protease
URI https://dx.doi.org/10.1016/j.steroids.2025.109638
https://www.ncbi.nlm.nih.gov/pubmed/40409429
https://www.proquest.com/docview/3207202705
Volume 220
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaqcoALgpZHeVRGQpzW3cSxE_u4WlEtIHqgLNpb5NiOmqrrVLvpoRz6Q_prmXESXgJx4Bg7j1G-0Tzsmc-EvLaaW_ACKXPaOSaqXDAllGTKJrXMNWhJgt3IH0_yxVK8X8nVDpmPvTBYVjnY_t6mR2s9jEyHvzm9bBrs8c00WNcVR07_QmPeLkSBWn5086PMAzxwzxieIe2_Wv3UJXx-hFwEbeOQtptLZFbKsU_lzw7qbwFodETHD8j9IYKks17Ih2THhz2yPwuQPa-v6RsaazrjYvkeuTsfz3PbJ7fLzdYET8-usUlrS3EFlkpm1k1oWTrhk2wiWBcrnxvztb3wE5qyznebeMEkzrUBRk1wv83gO_w2TkS6WtrWNO5A0CacNVWsCsOxtWkCPZ19OmXz9gvjNJJEgBt9RJbHbz_PF2w4mYFZiDc65qRRdeUL7bM0E1YZb41Sgnulqix3gC_cUCW1kMoWuce6LAdxixaF15BB2uwx2Q0g8lNCda3z1EhZadyz9Rp5k60SRjvutErlAZmOcJSXPQFHOVamnZcjgCUCWPYAHhA9olb-okoleIl_PvtqhLkEeHDzBJBpr7ZlxpMCF4oSkOhJj_93eUSCWTLXz_7jy8_JPbzqawtfkN1uc-VfQrzTVYdRoQ_Jndm7D4uTb2UD_do
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtQwFLVKWZQNghZoeRoJWI07iWMn9oLFaKCa0seCdtDsghM7aiomqWZSoWHBh_Ab_CD3OgkvgVigLmPnceXj3OvHuceEPMs1zyEKhMxqa5nIYsGUUJKpPChkrKGXBJiNfHQcT6bizUzO1sjXPhcGaZWd7299uvfWXcmwa83hRVlijm-kwbvOOGr6JzromJUHbvUR5m3Ll_uvAOTnnO-9Ph1PWHe0AMshYDbMSqOKzCXaRWEkcmVcbpQS3CmVRbEFA-GGLCiEVHkSOyQWWQi8WiROwxQoj-C918h1Ae4Cj03Y_fyDVwIhv5Uoj_CcATX7KS35fBfFD-rSok44lyjlFGNizJ8j4t9GvD7y7d0iN7shKx21rXKbrLlqk2yNKpiuz1f0BfUkUr86v0k2xv0Bclvky3SxNJWjZyvMCltSXPKlkpl5WdUsHPBBNBCs8VTr0nyqP7gBDVnjmoW_YBLr6gpKTWV_q8F3uKWv8Pq4tC6o3_KgZXVWZp6GhmVzU1b0ZPT2hI3rd4xTr0oBcfsOmV4JXnfJegUmbxOqCx2HRspM4yax0yjUnCthtOVWq1DukGEPR3rRKn6kPRXuPO0BTBHAtAVwh-getfSXvptCWPrns097mFOAB3drAJn6cplGPEhwZSoAi-61-H-3RwQ4Lef6_n98-QnZmJweHaaH-8cHD8gNrGmJjQ_JerO4dI9gsNVkj33npuT9Vf9N3wCzKDk_
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ursane+hybrids+with+5-amino-1%2C2%2C3%2C4-thiatriazole%2C+1-tetrazole-5-thione%2C+and+1-tetrazole-5-amines+and+study+of+their+inhibition+of+main+SARS-CoV-2+protease&rft.jtitle=Steroids&rft.au=Popov%2C+Sergey+A&rft.au=Shults%2C+Elvira+E&rft.au=Baev%2C+Dmitry+S&rft.au=Chirkova%2C+Varvara+Yu&rft.date=2025-08-01&rft.eissn=1878-5867&rft.volume=220&rft.spage=109638&rft_id=info:doi/10.1016%2Fj.steroids.2025.109638&rft_id=info%3Apmid%2F40409429&rft.externalDocID=40409429
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-128X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-128X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-128X&client=summon